We are pleased to share with you an important upcoming event at the European Parliament, focused on strengthening paediatric research, prevention, and child health within future EU health and research policy.
As EAP national member societies and subspecialty societies, your involvement is key. This initiative depends on the voice, experience, and reach of national paediatric societies across Europe, both in shaping the discussion and in helping ensure that child health research is recognised as a shared policy priority.
In parallel with the event, EAP and partner societies are preparing a position paper with key recommendations for improving EU policy on research to promote child health, innovation, and prevention. The position paper is expected to become available at the end of May, and we would greatly welcome your formal support as co-signatories.
Given the short timeline, we would be grateful if you could share the event information as soon as possible with your national Ministry of Health, national Ministry of Research and Innovation, and relevant national contact points to the EU, and invite them to join the event or engage with this important discussion.
The event, taking place on 4 June 2026 at the European Parliament in Brussels, will bring together European paediatric societies, policymakers, researchers, and EU stakeholders to discuss dedicated paediatric research infrastructure, funding, data sharing, prevention, innovation, and the inclusion of child-specific needs in the next EU research framework programme, FP10.
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.
